78 reports

  • 14. TRANSPLANT DIAGNOSTICS MARKET-KEY COMPANY PROFILES
  • 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET - MARKET LANDSCAPE

SOUTH AND CENTRAL AMERICA TRANSPLANT DIAGNOSTICS MARKET REVENUE, ##.

  • Diagnostics
  • Healthcare
  • Molecular Diagnostics
  • Transplantation
  • Illumina, Inc.
  • COMPANION DIAGNOSTIC TESTS PIPELINE, 2014
  • PROVIDES A SWOT ANALYSIS OF ILLUMINA IN THE COMPANION DIAGNOSTIC MARKET.

FIGURE ## SHOWS THE REASONS FOR COMPANION DIAGNOSTIC TEST FAILURE.

  • Cancer
  • Diagnostics
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PIPELINE COMPANION DIAGNOSTIC TESTS, 2018 (6/8)
  • MARKETED COMPANION DIAGNOSTIC TESTS, US, 2018 (3/5)

AND WHAT WE DO IF ONE' S GOT A CE MARK and one doesn' t, or what HAPPENS IF ONE HAS THIS LICENSE AND THE OTHER HAS THE CE MARK?

  • Biotech Diagnostics
  • Diagnostics
  • Abbott Molecular Inc.
  • Illumina, Inc.
  • Roche Group
  • HIGH COST OF TRANSPLANT DIAGNOSTICS
  • GLOBAL TRANSPLANT DIAGNOSTICS MARKET BY MOLECULAR ASSAYS

AlloMap system by CareDx is one such device used for posttransplant diagnostics.

  • Diagnostics
  • United States
  • World
  • Market Size
  • Illumina, Inc.
  • 4 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY
  • 6 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY SCREENING METHODS

PHONE: +## ##I##-##-## FAX: +## ##-##-## WEBSITE: WWW. CAREDX. COM ##. ##. ## OVERVIEW CAREDX, INC., A MOLECULAR DIAGNOSTIC COMPANY, DEVELOPS AND COMMERCIALIZES A DIAGNOSTIC SURVEILLANCE SOLUTION FOR TRANSPLANT RECIPIENTS.

  • Diagnostics
  • Healthcare
  • Molecular Diagnostics
  • Transplantation
  • Illumina, Inc.
  • 12.2 THERMO FISHER SCIENTIFIC
  • 3. Global Next Generation Sequencing (NGS) Market Share and Forecast (2014 - 2025)

Diagnostic odysseys often include serial molecular testing of one or a few genes, running up the costs of diagnosis.

  • Biotech Diagnostics
  • Diagnostics
  • Genome Sequencing
  • Molecular Diagnostics
  • Illumina, Inc.
  • Market size: Global genetic testing market
  • AVAILABILITY OF NGS FOR PRESENT AND FUTURE GENETIC DIAGNOSIS

Analyzers are a one-time investment.

  • Biotech Diagnostics
  • Diagnostics
  • Genetic Testing
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • 6.3 Performance of Key Players
  • 12. Prenatal And Newborn Genetic Testing Market-Key Company Profiles

Figure ##. ##.

  • Biotech Diagnostics
  • Diagnostics
  • Genetic Testing
  • Medical Biotechnology
  • Illumina, Inc.
  • ACQUISITIONS
  • 11.2 COMPETITIVE SCENARIO

One of the key areas of focus of this initiative was the creation of a genetic database of citizens in Japan and the promotion of new diagnostic solutions.

  • Diagnostics
  • Genomics
  • Genomics Proteomics And Enabling Technology
  • Molecular Diagnostics
  • Illumina, Inc.
  • 10. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User
  • 6.2 Market Positioning

Chromosomal analysis is one of the most frequently performed tests in the laboratory prenatal diagnostics.

  • Biotech Diagnostics
  • Diagnostics
  • Genetic Testing
  • Healthcare
  • Illumina, Inc.

Figure ##. ##.

  • Diagnostics
  • Genome Sequencing
  • Genomics Proteomics And Enabling Technology
  • Middle East
  • Illumina, Inc.
  • August, 2018
  • RECENT OTHER STRATEGIES IN THE DNA NGS MARKET , 2016-2018

FIGURE ##.

  • Biotech Diagnostics
  • Diagnostics
  • DNA
  • Molecular Diagnostics
  • Illumina, Inc.
  • PRODUCT ENHANCEMENT & SOFTWARE UPGRADATION IN THE GENOMICS MARKET
  • Untitled

TABLE ##.

  • Diagnostics
  • Genomics
  • Genomics Proteomics And Enabling Technology
  • Forecast
  • Illumina, Inc.
  • NIPT MARKET SHARE ANALYSIS BY MAJOR PLAYERS (2017) (%)
  • 11.9.5 BUSINESS STRATEGY

Exosome Diagnostics is one of the major player which employs Exosome based liquid biopsy.

  • Cancer
  • Diagnostics
  • Genetic Testing
  • Healthcare
  • Illumina, Inc.
  • 15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market
  • 15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market

TABLE ##. ##.

  • Biotech Diagnostics
  • Diagnostics
  • Molecular Diagnostics
  • RNA
  • Illumina, Inc.
  • RECENT PARTNERSHIP IN THE GENOMICS MARKET
  • Threats

TABLE ##.

  • Diagnostics
  • Genomics
  • Molecular Diagnostics
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • RECENT PARTNERSHIP IN THE GENOMICS MARKET
  • Threats

FIGURE ##.

  • Diagnostics
  • Genomics
  • Molecular Diagnostics
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • RECENT OTHER STRATEGIES IN THE NGS MARKET, 2016-2018
  • 12.7 Agilent Technologies

LIST OF FIGURES Figure ##.

  • Biotech Diagnostics
  • Diagnostics
  • Genome Sequencing
  • Molecular Diagnostics
  • Illumina, Inc.
  • LIQUID BIOPSY MARKET: COMPETITIVE LANDSCAPE
  • 6.2.2 KEY STRATEGIES - PRODUCT LAUNCHES - 3

Strobeck, Jack Schuler, Oracle Investment Management Inc. ## 2013 Celsee Diagnostics (US) ## Debt Financing Ann Arbor SPARK ## 2012 Biodesix, Inc.

  • Diagnostics
  • Genetic Testing
  • Biocept, Inc.
  • Biodesix Inc.
  • Illumina, Inc.
  • PRODUCT ENHANCEMENT & SOFTWARE UPGRADATION IN THE GENOMICS MARKET
  • RECENT PARTNERSHIP IN THE GENOMICS MARKET

The Insight Partners is a one stop industry research provider of actionable solutions.

  • Diagnostics
  • Genomics
  • Molecular Diagnostics
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PHARMACEUTICAL & LIFE SCIENCE RESEARCH
  • Some of the new products launched by major players in the last three years have been mentioned below:

Disease diagnostics is one of the major applications of microfluidic devices.

  • Diagnostics
  • In Vitro Diagnostics
  • Nanobiotechnology
  • Forecast
  • Illumina, Inc.
  • RECENT OTHER STRATEGIES IN THE NGS MARKET, 2016-2018
  • Challenging market environment due to large number of players

Other business areas covered under diagnostics are Tissue Diagnostics, Molecular Diagnostics, Centralised and Point of Care Solutions, & Diabetes Care.

  • Diagnostics
  • Europe
  • World
  • Market Size
  • Illumina, Inc.
  • THREATS
  • INORGANIC DEVELOPMENTS 12.4.1 OVERVIEW

Moreover, around one in three men and one in four women is likely to be diagnosed with cancer at the age of ##.

  • Biomarker
  • Cancer
  • Diagnostics
  • Genomics Proteomics And Enabling Technology
  • Illumina, Inc.
  • RECENT OTHER STRATEGIES IN THE NGS MARKET, 2016-2018
  • INORGANIC GROWTH STRATEGIES

Next Generation Sequencing (NGS) is one of the most significant advances in genomic technologies with regards to oncogenic biomarker discovery and diagnostics.

  • Biotech Diagnostics
  • Diagnostics
  • Genome Sequencing
  • Molecular Diagnostics
  • Illumina, Inc.
  • COMPETITIVE SCENARIO

In 2017, the company entered into an agreement to acquire Tulip Diagnostics, one of the largest domestic providers of diagnostic reagents.

  • Bioinformatics
  • Diagnostics
  • World
  • Forecast
  • Illumina, Inc.
  • 13.10.1 Recent Partnerships by Players in the Biotechnology Market
  • THREATS

Next Generation Sequencing (NGS) is one of the most significant advances in genomic technologies with regards to oncogenic biomarker discovery and diagnostics.

  • Biotechnology
  • Diagnostics
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Merck & Co., Inc.
  • RECENT OTHER STRATEGIES IN THE NGS MARKET, 2016-2018
  • Opportunities

LIST OF FIGURES FIGURE ##.

  • Diagnostics
  • North America
  • Forecast
  • Market Size
  • Illumina, Inc.
  • 4 BIOCHIPS GLOBAL MARKET, BY TECHNOLOGY

FROM DECEMBER, 2013 LIFE SCIENCES AND DIAGNOSTICS SEGMENTS OF THE COMPANY MERGED TO OPERATE AS ONE SEGMENT.

  • Bioinformatics
  • Diagnostics
  • Molecular Diagnostics
  • World
  • Illumina, Inc.
  • DRUG DISCOVERY
  • Revenue Breakdown (%), by Geography, 2017

The company has one of the broadest portfolios of molecular diagnostic technologies for healthcare.

  • Biotech Diagnostics
  • Diagnostics
  • Drug Development
  • Molecular Diagnostics
  • Illumina, Inc.
  • 5.4.3 MOLECULAR DIAGNOSTIC PRODUCTS FOR ONCOLOGY TESTING CURRENTLY AVAILABLE
  • MAJOR BUSINESS TRANSACTIONS IN THE MOLECULAR

One the leading testing service providers for neurological diagnostics is the Athena Diagnostics unit of Quest Diagnostics.

  • Biotech Diagnostics
  • Diagnostics
  • Infectious Disease
  • Molecular Diagnostics
  • Illumina, Inc.